Literature DB >> 29607154

Decreased expression of hepatic cytochrome P450 1A2 (CYP1A2) in a chronic intermittent hypoxia mouse model.

Xiao-Bin Zhang1, Yi-Ming Zeng1, Xiao-Yang Chen1, Yi-Xiang Zhang1, Jin-Zhen Ding1, Cheng Xue1.   

Abstract

BACKGROUND: Hepatic cytochrome P450 (CYP) isoforms, CYP1A2, is one of important enzymes for many drugs metabolism. Studies have confirmed that sustained hypoxia can influence the expression of hepatic CYP, including CYP1A2. The impact of chronic intermittent hypoxia (CIH), a marked characteristic of sleep apnea, on CYP1A2 remains unclear. The aim of the present study was to evaluate the effect of CIH on the expression of hepatic CYP1A2 in a mouse model with sleep apnea.
METHODS: Twenty four old male (6-8 weeks) C57BL/6J mice (n=12 in each group) were randomly assigned to either normoxia group or CIH group. Mice in CIH group underwent 12 weeks intermittent hypoxia exposure. The different gene expression of hepatic CYP1A2 between two groups was analyzed by quantity real-time polymerase chain reaction. The protein levels of hepatic CYP1A2 in each group were observed by using western blotting and immunohistochemistry.
RESULTS: After 12 weeks of exposure to intermittent hypoxia, the expression of hepatic CYP1A2, at the mRNA and protein levels was decreased more significantly in the CIH group than the normoxia group (P<0.01).
CONCLUSIONS: CIH contributes to inhibiting the expression of hepatic CYP1A2. This implies that the dosage of drugs metabolized by CYP1A2, should be adjusted in patients with sleep apnea.

Entities:  

Keywords:  Intermittent hypoxia; cytochrome P450 1A2 (CYP1A2); drug metabolism; hepatic cytochrome P450 (hepatic CYP); sleep apnea

Year:  2018        PMID: 29607154      PMCID: PMC5864663          DOI: 10.21037/jtd.2017.12.106

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  39 in total

1.  Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2.

Authors:  David R Plowchalk; Karen Rowland Yeo
Journal:  Eur J Clin Pharmacol       Date:  2012-01-19       Impact factor: 2.953

2.  Effect of exposure to acute and chronic high-altitude hypoxia on the activity and expression of CYP1A2, CYP2D6, CYP2C9, CYP2C19 and NAT2 in rats.

Authors:  Xiangyang Li; Xuejun Wang; Yongping Li; Ming Yuan; Junbo Zhu; Xiaodong Su; Xingchen Yao; Xueru Fan; Yabin Duan
Journal:  Pharmacology       Date:  2014-02-15       Impact factor: 2.547

3.  Network analysis of temporal effects of intermittent and sustained hypoxia on rat lungs.

Authors:  Wei Wu; Nilesh B Dave; Guoying Yu; Patrick J Strollo; Elizabeta Kovkarova-Naumovski; Stefan W Ryter; Stephen R Reeves; Ehab Dayyat; Yang Wang; Augustine M K Choi; David Gozal; Naftali Kaminski
Journal:  Physiol Genomics       Date:  2008-09-30       Impact factor: 3.107

4.  Chronic intermittent hypoxia predisposes to liver injury.

Authors:  Vladimir Savransky; Ashika Nanayakkara; Angelica Vivero; Jianguo Li; Shannon Bevans; Philip L Smith; Michael S Torbenson; Vsevolod Y Polotsky
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

5.  Evaluation of hepatic metabolism and pharmacokinetics of ibuprofen in rats under chronic hypobaric hypoxia for targeted therapy at high altitude.

Authors:  Shefali Gola; Asheesh Gupta; Gaurav K Keshri; Madhu Nath; Thirumurthy Velpandian
Journal:  J Pharm Biomed Anal       Date:  2016-01-12       Impact factor: 3.935

Review 6.  Hypoxia, arterial pH and theophylline disposition.

Authors:  M Richer; Y W Lam
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

7.  The association between continuous positive airway pressure therapy and liver disease development in obstructive sleep apnea/hypopnea syndrome patients: a nationwide population-based cohort study in Taiwan.

Authors:  Liang-Wen Hang; Chi-Fung Chen; Chang-Bi Wang; Trong-Neng Wu; Wen-Miin Liang; Tzu-Chieh Chou
Journal:  Sleep Breath       Date:  2016-12-13       Impact factor: 2.816

8.  Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver.

Authors:  Kathrin Klein; Stefan Winter; Miia Turpeinen; Matthias Schwab; Ulrich M Zanger
Journal:  Front Pharmacol       Date:  2010-11-02       Impact factor: 5.810

9.  Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  Salvatore Petta; Oreste Marrone; Daniele Torres; Maria Buttacavoli; Calogero Cammà; Vito Di Marco; Anna Licata; Anna Lo Bue; Gaspare Parrinello; Antonio Pinto; Adriana Salvaggio; Antonino Tuttolomondo; Antonio Craxì; Maria Rosaria Bonsignore
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

10.  Adiponectin protects the rats liver against chronic intermittent hypoxia induced injury through AMP-activated protein kinase pathway.

Authors:  Wenxiao Ding; Qiang Zhang; Yanbin Dong; Ning Ding; Hanpeng Huang; Xianji Zhu; Sean Hutchinson; Xingya Gao; Xilong Zhang
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

View more
  7 in total

Review 1.  Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes.

Authors:  Yeo-Jung Kwon; Sangyun Shin; Young-Jin Chun
Journal:  Arch Pharm Res       Date:  2021-01-23       Impact factor: 4.946

2.  Telmisartan attenuates kidney apoptosis and autophagy-related protein expression levels in an intermittent hypoxia mouse model.

Authors:  Xiao-Bin Zhang; Jing-Huang Cai; Yu-Yun Yang; Yi-Ming Zeng; Hui-Qing Zeng; Miao Wang; Xiao Cheng; Xiongbiao Luo; Henry Chidozie Ewurum
Journal:  Sleep Breath       Date:  2018-09-15       Impact factor: 2.816

3.  Sodium Tanshinone IIA Sulfonate Attenuates Tumor Oxidative Stress and Promotes Apoptosis in an Intermittent Hypoxia Mouse Model.

Authors:  Xiao-Bin Zhang; Xiao-Yang Chen; Peng Sun; Xiao-Man Su; Hui-Qing Zeng; Yi-Ming Zeng; Miao Wang; Xiongbiao Luo
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

4.  Intermittent Hypoxia Inhibits Hepatic CYP1a2 Expression and Delays Aminophylline Metabolism.

Authors:  Xiao-Bin Zhang; Xiao-Yang Chen; Kam Yu Chiu; Xiu-Zhen He; Jian-Ming Wang; Hui-Qing Zeng; Yiming Zeng
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-29       Impact factor: 2.650

5.  Erratum to decreased expression of hepatic cytochrome P450 1A2 (CYP1A2) in a chronic intermittent hypoxia mouse model.

Authors: 
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 2.895

6.  Comparative Transcriptome Analysis of Gill Tissue in Response to Hypoxia in Silver Sillago (Sillago sihama).

Authors:  Wanida Saetan; Changxu Tian; Jiawang Yu; Xinghua Lin; Feixiang He; Yang Huang; Hongjuan Shi; Yulei Zhang; Guangli Li
Journal:  Animals (Basel)       Date:  2020-04-06       Impact factor: 2.752

7.  Differential expression of microRNAs in xenografted Lewis lung carcinomas subjected to intermittent hypoxia: a next-generation sequence analysis.

Authors:  Xiao-Bin Zhang; Xiu-Li Lin; Xin-Yu Wu; Yi-Ming Zeng; Xiao-Yang Chen; Xiongbiao Luo; Hui-Qing Zeng
Journal:  Transl Cancer Res       Date:  2020-07       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.